Human medicines European public assessment report (EPAR): Cancidas (previously Caspofungin MSD), caspofungin, Date of authorisation: 23/10/2001, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR): Kyprolis, carfilzomib, Date of authorisation: 19/11/2015, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): Aerinaze, desloratadine,pseudoephedrine, Date of authorisation: 30/07/2007, Revision: 23, Status: Authorised

Update webinar on Regulatory Procedure Management for Product Lifecycle Management on IRIS, Online, from 13 February 2024, 10:00 (CET) to 13 February 2024, 11:30 (CET)

Variations not requiring assessment (veterinary medicines)

Focus group on veterinary pharmacovigilance reporting in poultry, European Medicines Agency, Amsterdam, the Netherlands, 11 October 2023

Orphan designation: fidanacogene elaparvovec Treatment of haemophilia B, 19/11/2018 Withdrawn

Orphan designation: Veliparib Treatment of ovarian cancer, 17/12/2010 Withdrawn

Orphan designation: Eflornithine Treatment of neuroblastoma, 27/09/2011 Withdrawn

Orphan designation: Genetically modified serotype 5/3 adenovirus coding for granulocyte macrophage colony-stimulating factor for the treatment of ovarian cancer Treatment of ovarian cancer, 29/04/2014 Withdrawn